MedTrace Logo

Implementing Dementia Care Management Into Routine Care in the Region Siegen-Wittgenstein

NCT05529277 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 93

Last updated 2024-06-10

No results posted yet for this study

Summary

Dementia Care Management (DeCM) is an evidence-based model of care in Germany. It has proven its efficacy and cost-effectiveness. However it has not been implemented into routine care so far.

The aim of this trial is to implement Dementia Care Management into routine care in a selected region in Germany and evaluate the process of implementation as well as the effect of Dementia Care Management on participants.

Recruited in regular routine care n=60 people with cognitive impairment and/ or their cares will receive Dementia Care Management provided by specifically trained and qualified dementia care managers for 6 months.

Data will be assessed and analysed prior to the implementation, immediately after having received the intervention and at a later time point.

The effect of the intervention on person-oriented health care outcomes wil be analysed as well as factors associated with that.

Conditions

Interventions

OTHER

Dementia Care Management

Comprehensive assessment of health care needs of person with cognitive impairment and caregiver followed by algorithm-/ and person-based support in health care planning, implementing and monitoring

Sponsors & Collaborators

  • University of Siegen

    collaborator UNKNOWN

  • Gesundheitsregion Siegerland eG (GRS)

    collaborator UNKNOWN

  • Alzheimer Gesellschaft Siegen-Wittgenstein eV

    collaborator UNKNOWN

  • Kreisklinikum Siegen

    collaborator UNKNOWN

  • Caritasverband Siegen-Wittgenstein eV

    collaborator UNKNOWN

  • German Center for Neurodegenerative Diseases (DZNE)

    lead OTHER

Principal Investigators

  • Jochen René Thyrian, Prof. Dr. · German Center for Neurodegenerative Diseases (DZNE)

  • Bernhard Holle, Dr. · German Center for Neurodegenerative Diseases (DZNE)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05529277 on ClinicalTrials.gov